Condition
Hypertensive Nephropathy
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed2
Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07240987Phase 1Not Yet Recruiting
Mesenchymal Stem Cells for Chronic Kidney Diseases
NCT07187713Phase 4RecruitingPrimary
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
NCT02477163Not ApplicableCompleted
Ayurvedic Management of Chronic Kidney Disease
NCT04633993Not ApplicableCompletedPrimary
Effectiveness of Implementation of a Patient-centered Self-management Program in Patients With Hypertensive Nephropathy
Showing all 4 trials